Pubblicazioni

Autori:

Caminati, Marco; Senna, Gianenrico; Maule, Matteo; Di Sabatino, Antonio; Rossi, Carlo Maria

Titolo:

Diagnosis, management and therapeutic options for eosinophilic esophagitis

Anno:

2024

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY

ISSN Rivista:

1528-4050

N° Volume:

24

Numero o Fascicolo:

3

Intervallo pagine:

122-128

Parole chiave:

biologic therapy; eosinophilic esophagitis; phenotype; type 2 inflammation

Breve descrizione dei contenuti:

Purpose of reviewEosinophilic esophagitis is a chronic and commonly evolving condition leading to relevant and potentially irreversible burden in terms of tissue damage and related functional impairment, thus significantly impacting on quality of life. The aim of the present review is to summarize the recent advances in terms of diagnostic work-up and pharmacological and nonpharmacological management of the disease, under the broader perspective of type 2 inflammation.Recent findingsTwo major novelties have prompted an innovative approach to EoE. In terms of diagnosis, it has been proposed to dissect the disease heterogeneity in three endotypes, independent from tissue eosinophil number: EoEe1, characterized by normal appearing oesophagus; EoEe2, associated with type 2 inflammation and steroid-refractoriness; EoEe3, whose features include adult onset, a more fibro-stenotic aspect and loss of epithelial gene expression. Concerning treatment, two recently licensed drugs for EoE, oro-dispersible budesonide and dupilumab represent the first treatment options specifically developed for EoE and addressing EoE-related peculiar pathobiological features.SummaryIn the era of precision medicine, managing EoE according to a phenotype-driven approach might be helpful in defining the best treatment options in the different disease forms or stages. In addition, exploring the coexistence or the previous occurrence of other type 2 conditions may suggest the opportunity to specifically target type 2 inflammation through biologic therapy. The complex EoE pathobiology combining inflammatory and functional features, both at organ and systemic level, requires a multidimensional approach relying on the strict integration of gastroenterologists and allergist-immunologists.

Id prodotto:

144436

Handle IRIS:

11562/1155710

ultima modifica:

20 aprile 2025

Citazione bibliografica:

Caminati, Marco; Senna, Gianenrico; Maule, Matteo; Di Sabatino, Antonio; Rossi, Carlo Maria, Diagnosis, management and therapeutic options for eosinophilic esophagitis «CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY» , vol. 24 , n. 3 , 2024 , pp. 122-128

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo